{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:50:08Z","timestamp":1793339408958,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2024JJ5480"],"award-info":[{"award-number":["2024JJ5480"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ60505"],"award-info":[{"award-number":["2023JJ60505"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ40860"],"award-info":[{"award-number":["2023JJ40860"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the European Research Council (ERC) under the European Union\u2019s Horizon 2020 Research and Innovation Program","award":["ERC-StG-2019-848325"],"award-info":[{"award-number":["ERC-StG-2019-848325"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373295"],"award-info":[{"award-number":["82373295"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82304424"],"award-info":[{"award-number":["82304424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Commission of Hunan province, China","award":["W20242009"],"award-info":[{"award-number":["W20242009"]}]},{"name":"Health Commission of Hunan province, China","award":["W20243128"],"award-info":[{"award-number":["W20243128"]}]},{"name":"Natural Science Foundation of Changsha, Hunan Province, China","award":["kq2208346"],"award-info":[{"award-number":["kq2208346"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M733962"],"award-info":[{"award-number":["2023M733962"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Postdoctoral Fellowship Program of CPSF","award":["GZB20230873"],"award-info":[{"award-number":["GZB20230873"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03091-w","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T03:34:39Z","timestamp":1736912079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Xinyan","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongbin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiemin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daxiong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"3091_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/now207","volume":"18","author":"QT Ostrom","year":"2016","unstructured":"Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2009\u20132013. Neuro Oncol. 2016;18:v1\u201375.","journal-title":"Neuro Oncol"},{"key":"3091_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"C Cancer","year":"2022","unstructured":"Global Burden of Disease, Cancer C, Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, Henrikson HJ, Lu D, Pennini A, et al. Cancer Incidence, Mortality, Years of Life Lost, Years lived with disability, and disability-adjusted life years for 29 Cancer groups from 2010 to 2019: a systematic analysis for the global burden of Disease Study 2019. JAMA Oncol. 2022;8:420\u201344.","journal-title":"JAMA Oncol"},{"key":"3091_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, Lopez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70:299\u2013312.","journal-title":"CA Cancer J Clin"},{"key":"3091_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccell.2018.05.012","volume":"34","author":"MS Pavlyukov","year":"2018","unstructured":"Pavlyukov MS, Yu H, Bastola S, Minata M, Shender VO, Lee Y, Zhang S, Wang J, Komarova S, Wang J, et al. Apoptotic cell-derived extracellular vesicles promote malignancy of Glioblastoma Via Intercellular transfer of splicing factors. Cancer Cell. 2018;34:119\u2013e135110.","journal-title":"Cancer Cell"},{"key":"3091_CR5","doi-asserted-by":"publisher","first-page":"100671","DOI":"10.1016\/j.mtbio.2023.100671","volume":"20","author":"LD Di Filippo","year":"2023","unstructured":"Di Filippo LD, de Carvalho SG, Duarte JL, Luiz MT, Paes Dutra JA, de Paula GA, Chorilli M, Conde J. A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas. Mater Today Bio. 2023;20:100671.","journal-title":"Mater Today Bio"},{"key":"3091_CR6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660\u20135.","journal-title":"Nature"},{"key":"3091_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, Sun H, Wang DC, Shao F. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535:111\u20136.","journal-title":"Nature"},{"key":"3091_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/2159-8290.CD-19-0672","volume":"10","author":"DA Erkes","year":"2020","unstructured":"Erkes DA, Cai W, Sanchez IM, Purwin TJ, Rogers C, Field CO, Berger AC, Hartsough EJ, Rodeck U, Alnemri ES, Aplin AE. Mutant BRAF and MEK inhibitors regulate the Tumor Immune Microenvironment via Pyroptosis. Cancer Discov. 2020;10:254\u201369.","journal-title":"Cancer Discov"},{"key":"3091_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei X, Xie F, Zhou X, Wu Y, Yan H, Liu T, Huang J, Wang F, Zhou F, Zhang L. Role of pyroptosis in inflammation and cancer. Cell Mol Immunol. 2022;19:971\u201392.","journal-title":"Cell Mol Immunol"},{"key":"3091_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K, Shao F. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99\u2013103.","journal-title":"Nature"},{"key":"3091_CR11","doi-asserted-by":"publisher","first-page":"8049","DOI":"10.1021\/acs.nanolett.9b03245","volume":"19","author":"JX Fan","year":"2019","unstructured":"Fan JX, Deng RH, Wang H, Liu XH, Wang XN, Qin R, Jin X, Lei TR, Zheng D, Zhou PH, et al. Epigenetics-based Tumor cells pyroptosis for enhancing the Immunological Effect of Chemotherapeutic Nanocarriers. Nano Lett. 2019;19:8049\u201358.","journal-title":"Nano Lett"},{"key":"3091_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jconrel.2017.03.017","volume":"263","author":"KF Timbie","year":"2017","unstructured":"Timbie KF, Afzal U, Date A, Zhang C, Song J, Wilson Miller G, Suk JS, Hanes J, Price RJ. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound. J Control Release. 2017;263:120\u201331.","journal-title":"J Control Release"},{"key":"3091_CR13","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.apsb.2021.10.013","volume":"12","author":"B Niu","year":"2022","unstructured":"Niu B, Zhou Y, Liao K, Wen T, Lao S, Quan G, Pan X, Wu C. Pincer movement: reversing cisplatin resistance based on simultaneous glutathione depletion and glutathione S-transferases inhibition by redox-responsive degradable organosilica hybrid nanoparticles. Acta Pharm Sin B. 2022;12:2074\u201388.","journal-title":"Acta Pharm Sin B"},{"key":"3091_CR14","doi-asserted-by":"publisher","first-page":"e2108624","DOI":"10.1002\/adma.202108624","volume":"34","author":"J Chen","year":"2022","unstructured":"Chen J, Pan S, Zhou J, Lin Z, Qu Y, Glab A, Han Y, Richardson JJ, Caruso F. Assembly of Bioactive nanoparticles via Metal-Phenolic Complexation. Adv Mater. 2022;34:e2108624.","journal-title":"Adv Mater"},{"key":"3091_CR15","doi-asserted-by":"publisher","first-page":"e1864","DOI":"10.1002\/wnan.1864","volume":"15","author":"L Xie","year":"2023","unstructured":"Xie L, Li J, Wang L, Dai Y. Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15:e1864.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"3091_CR16","doi-asserted-by":"publisher","first-page":"e1906024","DOI":"10.1002\/adma.201906024","volume":"32","author":"Z Ren","year":"2020","unstructured":"Ren Z, Sun S, Sun R, Cui G, Hong L, Rao B, Li A, Yu Z, Kan Q, Mao Z. A metal-polyphenol-coordinated nanomedicine for synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy. Adv Mater. 2020;32:e1906024.","journal-title":"Adv Mater"},{"key":"3091_CR17","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jconrel.2020.11.006","volume":"330","author":"J Xiang","year":"2021","unstructured":"Xiang J, Li Y, Zhang Y, Wang G, Xu H, Zhou Z, Tang J, Shen Y. Polyphenol-cisplatin complexation forming core-shell nanoparticles with improved tumor accumulation and dual-responsive drug release for enhanced cancer chemotherapy. J Control Release. 2021;330:992\u20131003.","journal-title":"J Control Release"},{"key":"3091_CR18","doi-asserted-by":"publisher","first-page":"13445","DOI":"10.1021\/acsnano.9b07032","volume":"13","author":"Y Xu","year":"2019","unstructured":"Xu Y, Han X, Li Y, Min H, Zhao X, Zhang Y, Qi Y, Shi J, Qi S, Bao Y, Nie G. Sulforaphane mediates glutathione depletion via Polymeric nanoparticles to restore cisplatin chemosensitivity. ACS Nano. 2019;13:13445\u201355.","journal-title":"ACS Nano"},{"key":"3091_CR19","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1039\/D2TB01150F","volume":"10","author":"Y Lu","year":"2022","unstructured":"Lu Y, Pan Q, Gao W, Pu Y, He B. Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis. J Mater Chem B. 2022;10:6296\u2013306.","journal-title":"J Mater Chem B"},{"key":"3091_CR20","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.7150\/thno.51797","volume":"11","author":"D Wang","year":"2021","unstructured":"Wang D, Zhao C, Xu F, Zhang A, Jin M, Zhang K, Liu L, Hua Q, Zhao J, Liu J, et al. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2. Theranostics. 2021;11:2860\u201375.","journal-title":"Theranostics"},{"key":"3091_CR21","doi-asserted-by":"publisher","first-page":"2204629","DOI":"10.1002\/adfm.202204629","volume":"32","author":"L Zhang","year":"2022","unstructured":"Zhang L, Du X, Li Q, Qian L, Chen J, Liu C, Yu Q, Gan Z. A Multimodal Therapeutic Nanoplatform overcoming Tumor Hypoxia Heterogeneity for Improved Tumor Chemoradiotherapy. Adv Funct Mater. 2022;32:2204629.","journal-title":"Adv Funct Mater"},{"key":"3091_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/neuonc\/nov172","volume":"18","author":"EK Nduom","year":"2016","unstructured":"Nduom EK, Wei J, Yaghi NK, Huang N, Kong LY, Gabrusiewicz K, Ling X, Zhou S, Ivan C, Chen JQ, et al. PD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol. 2016;18:195\u2013205.","journal-title":"Neuro Oncol"},{"key":"3091_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jconrel.2022.11.055","volume":"353","author":"T Davenne","year":"2023","unstructured":"Davenne T, Percier P, Larbanoix L, Moser M, Leo O, Meylan E, Goriely S, Gerard P, Wauthoz N, Laurent S, et al. Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model. J Control Release. 2023;353:317\u201326.","journal-title":"J Control Release"},{"key":"3091_CR24","doi-asserted-by":"crossref","unstructured":"Brown MC, Holl EK, Boczkowski D, Dobrikova E, Mosaheb M, Chandramohan V, Bigner DD, Gromeier M, Nair SK. Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs. Sci Transl Med 2017, 9.","DOI":"10.1126\/scitranslmed.aan4220"},{"key":"3091_CR25","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","volume":"22","author":"T Yin","year":"2022","unstructured":"Yin T, Fan Q, Hu F, Ma X, Yin Y, Wang B, Kuang L, Hu X, Xu B, Wang Y. Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce Immunomodulation for a synergistic and targeted Antiglioblastoma Activity. Nano Lett. 2022;22:6606\u201314.","journal-title":"Nano Lett"},{"key":"3091_CR26","doi-asserted-by":"publisher","first-page":"e2311109","DOI":"10.1002\/adma.202311109","volume":"36","author":"Y Dong","year":"2024","unstructured":"Dong Y, Zhang J, Wang Y, Zhang Y, Rappaport D, Yang Z, Han M, Liu Y, Fu Z, Zhao X, et al. Intracavitary Spraying of Nanoregulator-Encased Hydrogel modulates cholesterol metabolism of glioma-supportive macrophage for postoperative Glioblastoma Immunotherapy. Adv Mater. 2024;36:e2311109.","journal-title":"Adv Mater"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03091-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03091-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03091-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T03:35:02Z","timestamp":1736912102000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03091-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3091"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03091-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed according to the protocols and reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of the Second Xiangya Hospital, Central South University, China (20220623).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"J.C. is a co-founder and shareholder of TargTex S.A. \u2013 Targeted therapeutics for Glioblastoma Multiforme. J.C. is also a member of the Global Burden Disease (GBD) consortium of the Institute for Health Metrics and Evaluation (IHME), University of Washington (US) and is in the Scientific Advisory board of Vector Bioscience Cambridge. The other authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}